Systematic review of the clinical effectiveness and cost-effectiveness, and economic evaluation, of denosumab for the treatment of bone metastases from solid tumours
Citation
Ford , J , Cummins , E , Sharma , P , Elders , A , Stewart , F , Johnston , R , Royle , P , Jones , R , Mulatero , C , Todd , R & Mowatt , G 2013 , ' Systematic review of the clinical effectiveness and cost-effectiveness, and economic evaluation, of denosumab for the treatment of bone metastases from solid tumours ' , Health Technology Assessment , vol. 17 , no. 29 , pp. 1-386 . https://doi.org/10.3310/hta17290
Rights
Ford, JA, Cummins, E, Sharma, P, Elders, A, Stewart, F, Johnston, R, Royle, P, Jones, R, Mulatero, C, Todd, R & Mowatt, G 2013, 'Systematic review of the clinical effectiveness and cost-effectiveness, and economic evaluation, of denosumab for the treatment of bone metastases from solid tumours' Health technology assessment (Winchester, England), vol 17, no. 29, pp. 1-386.